|
|
|
Volumn 11, Issue SUPPL. 3, 1997, Pages 54-56
|
|
Adult T-cell leukemia/lymphoma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CD4 ANTIGEN;
VIRUS DNA;
HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;
ADULT;
AGED;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER EPIDEMIOLOGY;
CLINICAL FEATURE;
CONFERENCE PAPER;
DISEASE ASSOCIATION;
FEMALE;
HUMAN;
HUMAN T CELL LEUKEMIA VIRUS 1;
INFECTION PREVENTION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
PROVIRUS;
SPASTIC PARAPLEGIA;
SPINAL CORD DISEASE;
T CELL LEUKEMIA;
T CELL LYMPHOMA;
T LYMPHOCYTE SUBPOPULATION;
UVEITIS;
VIRUS TRANSMISSION;
ARTICLE;
BLOOD;
DIFFERENTIAL DIAGNOSIS;
INCIDENCE;
ISOLATION AND PURIFICATION;
JAPAN;
PATHOLOGY;
SURVIVAL RATE;
T LYMPHOCYTE;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DIAGNOSIS, DIFFERENTIAL;
DNA, VIRAL;
FEMALE;
HTLV-I ANTIBODIES;
HUMAN T-LYMPHOTROPIC VIRUS 1;
HUMANS;
INCIDENCE;
JAPAN;
LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED;
MALE;
PROVIRUSES;
SURVIVAL RATE;
T-LYMPHOCYTES;
|
|
EID: 0031111778
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (1)
|
